venBio Partners LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001776382 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value: $194M (100.0% shares, 0.0% debt)

Holdings (6)

PHVS PHARVARIS N V 40.9%

Value $79.44M Shares 4,289,304 Share Price $18.52 Est. Cost/Share $21.15 Unrealized @ Report Date -13.6%

ALMS ALUMIS INC 15.5%

Value $30.18M Shares 2,826,048 Share Price $10.68 * Est. Cost/Share $13.30 Unrealized @ Report Date -8.8%

HRMY HARMONY BIOSCIENCES HLDGS IN 12.7%

Value $24.58M Shares 614,594 Share Price $40.00 * Est. Cost/Share $36.46 Unrealized @ Report Date -3.7%

ARTV ARTIVA BIOTHERAPEUTICS INC 12.1%

Value $23.48M Shares 1,519,971 Share Price $15.45 * Est. Cost/Share $11.59 Unrealized @ Report Date 0.0%

— ACELYRIN INC 9.8%

Value $18.99M Shares 3,852,470 Share Price $4.93 Est. Cost/Share $20.90 Unrealized @ Report Date —

ALXO ALX ONCOLOGY HLDGS INC 9.1%

Value $17.65M Shares 9,699,925 Share Price $1.82 * Est. Cost/Share $39.31 Unrealized @ Report Date -90.5%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
PHVS	PHARVARIS N V	4,289,304	$79.44M	40.9%	$18.52	$21.15	-13.6%	COM	N69605108
ALMS	ALUMIS INC	2,826,048	$30.18M	15.5%	$10.68 *	$13.30	-8.8%	COM	022307102
HRMY	HARMONY BIOSCIENCES HLDGS IN	614,594	$24.58M	12.7%	$40.00 *	$36.46	-3.7%	COM	413197104
ARTV	ARTIVA BIOTHERAPEUTICS INC	1,519,971	$23.48M	12.1%	$15.45 *	$11.59	0.0%	COM	04317A107
—	ACELYRIN INC	3,852,470	$18.99M	9.8%	$4.93	$20.90	—	COM	00445A100
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$17.65M	9.1%	$1.82 *	$39.31	-90.5%	COM	00166B105